క్లినికల్ & మెడికల్ బయోకెమిస్ట్రీ

నైరూప్య

Traditional Treatment of COVID-19 in Children with Para’s Mushrooms

John Dolittle, Gregory House, Stephen Strange, John Michael Dorian, Mattan Schlomi

Objective: The COVID-19 pandemic caused by the SARS-CoV-II virus has had an outsized effect on children. This has lead to an abundant interest in research on COVID and publications thereof. A traditional Chinese medicine commonly used as a tonic in the Kanto region of Japan, the mushroom naturally growing on the back of Paras and Parasects, is tested for its ability to fight the virus. Methods: This is a retrospective cohort study comparing children seen at three hospitals with positive COVID-19 tests. Symptom intensity and duration and recovery length and outcome were compared between who reported treatment with Paras mushrooms and those who did not. Results: While most parents of the Paras-taking cohort reported positive experiences and believed the mushrooms aided in their children’s recoveries, no significant differences were found in the duration of illness or final outcomes between those taking the fungus and those who did not. Children who took the mushroom and recovered returned to school sooner than those who did not and also recovered.